America in Transition Pages

Wednesday, July 13, 2016

FDA Panel Backs Biosimilar for Humira

(MedPage Today) -- But patent dispute could delay availability till 2022

from MedPage Today Washington Watch http://ift.tt/29OfYdx
via IFTTT

No comments:

Post a Comment